JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SHORT, C. R.
Right arrow Articles by DAVIS, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SHORT, C. R.
Right arrow Articles by DAVIS, L. E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 174, Issue 2, 185-196, 1970
Copyright © 1970 by American Society for Pharmacology and Experimental Therapeutics


PERINATAL DEVELOPMENT OF DRUG-METABOLIZING ENZYME ACTIVITY IN SWINE

CHARLES R. SHORT 1 and LLOYD E. DAVIS 1

1 Section of Comparative Pharmacology, College of Veterinary Medicine, University of Missouri, Columbia, Missouri

Three oxidative, one reductive, one hydrolytic and one synthetic mechanism were studied in vitro utilizing preparations of liver and kidney obtained from pigs at weekly intervals from the 100th day of gestation through the 10th week postpartum. The oxidation of hexobarbital, l-amphetamine, p-nitroanisole and zoxazolamine, the hydrolysis of procaine and the glucuronidation of phenolphthalein occurred at very low rates in the tissues of the fetal and newborn pig, whereas the capacity for azo reduction of Neoprontosil by both tissues was evident at these ages. The postnatal pattern of development in liver appeared to be biphasic in nature, with the greatest rate of increase in activity occurring during the first three to four weeks postpartum for all pathways except azo reduction (four to six weeks). The reductive and hydrolytic mechanisms developed slowly in kidney after birth, whereas the capacity of this organ for oxidative metabolism or for glucuronic acid conjugation was insignificant at all ages. The content of glycogen in the liver at various ages after birth did not correlate well with the development of drug-metabolizing enzyme activity over the entire period studied. The CO-binding pigment (cytochrome P-450) of hepatic microsomes developed in parallel with the oxidative and reductive pathways, suggesting that this cytochrome may be rate-limiting to the development of these pathways.

Submitted on September 3, 1969
Accepted on April 10, 1970







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics.